Science Explorer Back to mapMap
Discussion

InterveXion Therapeutics (United States)

Research works
4
▲ 33% vs 2018-21
Citations
39
8.8 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
60%
world 40%
International
3%
world 18%
InterveXion Therapeutics (United States)

Not ranked overall: InterveXion Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does InterveXion Therapeutics (United States) work in?

In all years, 75% of research at InterveXion Therapeutics (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Neuroscience (41%), Medicine (25%), Pharmacology, Toxicology and Pharmaceutics (20%). It does 1.7× the world's share of Life Sciences.

Life Sciences75%Health Sciences25%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Neuroscience240.9%
    2. Pharmacology, Toxicology and Pharmaceutics120.5%
    3. Biochemistry, Genetics and Molecular Biology113.6%
    1. Medicine125.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from InterveXion Therapeutics (United States)?

The most cited paper from InterveXion Therapeutics (United States) is "First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers" (Misty W. Stevens, Ralph L. Henry, Samuel Michael Owens et al., 2014), with 47 citations. Next come "Optimization of a methamphetamine conjugate vaccine for antibody production in mice" (33) and "Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use" (32).

Most cited papers
#PaperReleasedCitations
1 First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers Misty W. Stevens, Ralph L. Henry, Samuel Michael Owens et al. · mAbs Open access 2 Nov 2014 47
2 Optimization of a methamphetamine conjugate vaccine for antibody production in mice Misty W. Stevens, Melinda G. Gunnell, Rachel Tawney et al. · International Immunopharmacology Open access 17 Apr 2016 33
3 Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use Misty W. Stevens et al. · mAbs Open access 23 Dec 2013 32
4 Pharmacological effects of two anti-methamphetamine monoclonal antibodies Elizabeth M. Laurenzana, Misty W. Stevens, John C Frank et al. · Human Vaccines & Immunotherapeutics Open access 8 Jul 2014 14
5 Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors Courtney M. Keller, Allyson L. Spence, Misty W. Stevens et al. · Psychopharmacology 22 Nov 2019 9
All 10 most cited papers, with filters and sorting

Which research topics does InterveXion Therapeutics (United States) publish most on?

By volume in 2022-now: Neurotransmitter Receptor Influence on Behavior, Forensic Toxicology and Drug Analysis and Monoclonal and Polyclonal Antibodies Research.

Neurotransmitter Recepto…1Neurotransmitter Receptor Influence on Behavior: 1 fractional worksForensic Toxicology and Drug Analysis: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional works
Cellular and Molecular NeuroscienceToxicologyRadiology, Nuclear Medicine and Imaging

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
  2. 2 Forensic Toxicology and Drug Analysis Toxicology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.5%not open39.5%

World: 40% of research is openly available.

with international co-authors3.2%domestic only96.8%

World: 18% is written across borders.

How has InterveXion Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 33% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Little Rock

All research institutions in Little Rock

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about InterveXion Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.